Posts Tagged ‘
investing in biotech ’
Oct 8th, 2009 |
By Marc Lichtenfeld |
Category: Stock Market Investing
The procedure has been called “one of the most barbaric mistakes ever perpetrated by mainstream medicine.” Back when medicine was highly primitive, the process involved shoving an ice pick-like instrument between the upper eyelid and the eye in hopes of severing certain nerves of the frontal lobe.
Tags: Bmy, CVM, CYTX, DNDN, GERN, investing in biotech, Marc Lichtenfeld, NWBO, Penny Stocks, Small Cap, STEM
Posted in Stock Market Investing |
No Comments »
Sep 25th, 2009 |
By J. Christoph Amberger |
Category: Stock Market Investing
It’s a rainy day and the markets are all but inspiring. So take gains on Dr. Reddy’s Laboratories Limited (NYSE:RDY) and buy yourself a cuppa cheer!
Tags: investing in biotech, J. Christoph Amberger, RDY, SVA
Posted in Stock Market Investing |
No Comments »
Sep 18th, 2009 |
By Patrick Cox |
Category: Financial News
The sequencing of the human genome has resulted in the emergence of an enormously important new branch in the biotechnological sciences. The most common terms for this field are bioinformatics or computational biology.
Tags: investing in agriculture, investing in biotech, Patrick Cox
Posted in Financial News |
No Comments »
Sep 9th, 2009 |
By Andrew Snyder |
Category: Stock Market Investing
Biopharma Vical (NASDAQ:VICL) has risen to its highest share price in a year — and with rumors of a buyout offer, it shows no sign of stopping.
Tags: Andrew Snyder, investing in biotech, TEVA, VICL
Posted in Stock Market Investing |
No Comments »
Sep 3rd, 2009 |
By Marc Lichtenfeld |
Category: Stock Market Investing
“You think they’re your friends, but they’re not your friends.” This was the frequent refrain from a landlord I had while in college. He was warning us on the danger of throwing parties and inviting people who we considered friends, but would think nothing of trashing the place.
Tags: College Kids, investing in biotech, Marc Lichtenfeld, MDVN
Posted in Stock Market Investing |
No Comments »
Aug 27th, 2009 |
By Andrew Snyder |
Category: Stock Market Investing
The best things come in little packages. We proved it once today. Kewaunee Scientific (NASDAQ:KEQU) may be your shot at another double-digit winner.
Tags: Andrew Snyder, BA, Ford, HD, investing in biotech, KEQU, Small Caps, SPNG
Posted in Stock Market Investing |
No Comments »
Aug 21st, 2009 |
By Jason Simpkins |
Category: Stock Market Investing
Monsanto Corp. (NYSE: MON), the world’s largest seed maker, says it’s on track to more than double its 2007 profit by the year 2012 and is expecting a “technology explosion” to provide even stronger products going forward. But while Monsanto continues to build on its reputation as a cutting edge agricultural business, it is also under siege by competitors and advocacy groups who claim the company is a monopoly.
Tags: DD, investing in agriculture, investing in biotech, Jason Simpkins, MON, resources
Posted in Stock Market Investing |
No Comments »
Aug 18th, 2009 |
By Patrick Cox |
Category: Stock Market Investing
Currently, medicine is, to a large degree, a “one size fits all” proposition. Doctors watch for adverse effects and check personal and family histories. Medical technologies, however, are designed for the general population, not individuals. That’s going to change.
Tags: DNA, investing in biotech, Patrick Cox, Pharmaceutical companies, Roche
Posted in Stock Market Investing |
No Comments »
Aug 7th, 2009 |
By Patrick Cox |
Category: Stock Market Investing
At the Agora Financial conference in Vancouver, I participated in a panel that attempted to name “the trade of the decade.” Many of the recommendations involved commodity or resource plays.
Tags: Commodity, inflation, investing in biotech, medical care, Patrick Cox, US market
Posted in Stock Market Investing |
No Comments »
Jul 30th, 2009 |
By Ted Peroulakis |
Category: Stock Market Investing
In June, the World Health Organization (WHO) alerted the public that a worldwide pandemic of swine flu (H1N1) was sweeping the globe. Health officials at the Centers for Disease Control and Prevention (CDC) have stated that the swine flu virus could infect up to 40% of Americans over the next couple of years. At last count, the CDC said there are 43,771 swine flu cases that have been reported in America, and 302 deaths have been associated with the disease.
Tags: BCRX, H1N1, investing in biotech, swine flu, Ted Peroulakis
Posted in Stock Market Investing |
No Comments »